1. 304 EPIDEMIOLOGICAL AND PROGNOSTIC FACTORS FROM THE ARGENTINEAN MDS REGISTRY. Issue 1 (April 2015) Authors: Gonzalez, J.; Flores, M.; Arbelbide, J.; Iabstrebner, M.; Nucifora, E.; Enrico, A.; Prates, V.; Rosenhain, M.; Koremblitt, L.; Crisp, R.; Alfonso, G.; Basquieras, A.; Martín, C.; Santos, I.; Barcalá, V.; Belli, C. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PET‐ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH‐05 TRIAL. (17th June 2021) Authors: Pavlovsky, A.; Fiad, L.; Fernandez, I.; Prates, V.; Kurgansky, N.; Cerutti, A.; Sackman, F.; Negri, F.; Zoppegno, L.; Negri, P.; Remaggi, G.; Ferrari, L.; Mariano, R.; Guanchiale, L.; Maradei, J.; Rudoy, S.; Giuliani, F.; Roveri, E.; Enrico, A.; Zabaljauregui, S. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAFETY AND EFFICACY ANALYSIS OF ELDERLY PATIENTS TREATED WITHIN THE GATLA HL‐05 CLINICAL TRIAL: PET ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA. (June 2017) Authors: Ciliberti, E.; Fernandez, I.; Kurgansky, N.; Prates, V.; Zoppegno, L.; Negri, P.; Milone, G.; Cerutti, I.; Zabaljauregui, S.; Mariano, R.; Fernandez Grecco, H.; Saba, S.; Sackmann, F.; Castano, V.; Remaggi, G.; Cabrejo, M.; Rudoy, S.; Roveri, E.; Cabane, V.; Gumpel, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗